Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.54 +0.07 (+2.02%)
As of: Oct 2, 2026 · 1:01 PM EDT

Insight Molecular Diagnostics (IMDX) Return on Assets [ROA] (2016 - 2026)

Updated

Insight Molecular Diagnostics' Return on Assets [ROA] was -141.29% in Q2 2026, down 26.90 percentage points from -114.39% a year earlier but up 3.28 percentage points from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) Return on Assets [ROA] (2016 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Insight Molecular Diagnostics came in at -165.10%, down 54.78 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of -102.37 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -110.32% in FY2024 (-78.57 pp), -31.75% in FY2023 (+24.40 pp), -56.15% in FY2022 (+3.48 pp) and -59.63% in FY2021 (+3.10 pp).
  • Quarterly Return on Assets [ROA] has moved between -144.57% (Q1 2026) and -20.15% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Assets [ROA] has declined for seven straight quarters, with an average year-over-year change of -43.96 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2021 (a gain of 31.94 percentage points); the worst was Q4 2024 (a drop of 79.72 percentage points).
  • Per Business Quant data, IMDX's Return on Assets [ROA] in the three quarters before Q2 2026 was -144.57% (Q1 2026), -144.12% (Q4 2025) and -128.69% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 6.17%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 4.94%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 4.54%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 15.41%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 5.66%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -1.94%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 8.19%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 7.38%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 1.85%
10 Insight Molecular Diagnostics 117.12 Mn 40.83 Mn 157,000.00 -141.29%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -141.29%
Mar 31, 2026 -144.57%
Dec 31, 2025 -144.12%
Sep 30, 2025 -128.69%
Jun 30, 2025 -114.39%
Mar 31, 2025 -121.97%
Dec 31, 2024 -115.22%
Sep 30, 2024 -59.54%
Jun 30, 2024 -49.61%
Mar 31, 2024 -54.77%
Dec 31, 2023 -35.51%
Sep 30, 2023 -67.13%
Jun 30, 2023 -69.99%
Mar 31, 2023 -65.15%
Dec 31, 2022 -56.64%
Sep 30, 2022 -38.74%
Jun 30, 2022 -42.91%
Mar 31, 2022 -45.96%
Dec 31, 2021 -38.98%
Sep 30, 2021 -20.15%
API Access

Insight Molecular Diagnostics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IMDX&period=max&api_key=YOUR_API_KEY